Response to COVID‐19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose

BACKGROUND: Coronavirus disease 2019 (COVID‐19) vaccination is recommended for patients with inflammatory bowel disease (IBD); however, suppressed immune responses have been reported for fully vaccinated patients under immunosuppressive therapy, mainly from Western countries. We prospectively analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiga, Hisashi, Kakuta, Yoichi, An, Kumiko, Abe, Yuko, Fujimaki, Shinichi, Shimoyama, Yusuke, Naito, Takeo, Moroi, Rintaro, Kuroha, Masatake, Khor, Seik‐Soon, Kawai, Yosuke, Tokunaga, Katsushi, Kinouchi, Yoshitaka, Masamune, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles ‐ Gastroenterology (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537921/
https://www.ncbi.nlm.nih.gov/pubmed/36066279
http://dx.doi.org/10.1111/jgh.16001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537921/
https://www.ncbi.nlm.nih.gov/pubmed/36066279
http://dx.doi.org/10.1111/jgh.16001

Ejemplares similares